Cardiovascular extracellular microRNAs: Emerging diagnostic markers and mechanisms of cell-to-cell RNA communication

Frontiers in Genetics

Volumn 4, Issue NOV, 2013, Pages

  Kinet, Virginie ^a   Halkein, Julie ^a   Dirkx, Ellen ^a   De Windt, Leon J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Biomarkers; Cardiovascular diseases; Extracellular microRNA; Inter cellular communications

Indexed keywords

EID: 84890263386     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2013.00214     Document Type: Review

References (68)

1. Adachi, T., Nakanishi, M., Otsuka, Y., Nishimura, K., Hirokawa, G., Goto, Y., et al. (2010). Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin. Chem. 56, 1183-1185. doi: 10.1373/clinchem.2010.144121.
2. Ai, J., Zhang, R., Li, Y., Pu, J., Lu, Y., Jiao, J., et al. (2010). Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem. Biophys. Res. Commun. 391, 73-77. doi: 10.1016/j.bbrc.2009.11.005.
3. Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., and Wood, M. J. (2011). Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. Biotechnol. 29, 341-345. doi: 10.1038/nbt.1807.
4. Arroyo, J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., et al. (2011). Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. U.S.A. 108, 5003-5008. doi: 10.1073/pnas.1019055108.
5. Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297. doi: 10.1016/S0092-8674(04)00045-5.
6. Bauters, C., Kumarswamy, R., Holzmann, A., Bretthauer, J., Anker, S. D., Pinet, F., et al. (2013). Circulating miR-133a and miR-423-5p fail as biomarkers for left ventricular remodeling after myocardial infarction. Int. J. Cardiol. doi: 10.1016/j.ijcard.2012.12.074 [Epub ahead of print].
7. Boon, R. A., and Vickers, K. C. (2013). Intercellular transport of MicroRNAs. Arterioscler. Thromb. Vasc. Biol. 33, 186-192. doi: 10.1161/ATVBAHA.112.300139.
8. Chen, L., Wang, Y., Pan, Y., Zhang, L., Shen, C., Qin, G., et al. (2013). Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury. Biochem. Biophys. Res. Commun. 431, 566-571. doi: 10.1016/j.bbrc.2013.01.015.
9. Cheng, Y., Tan, N., Yang, J., Liu, X., Cao, X., He, P., et al. (2010). A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin. Sci. 119, 87-95. doi: 10.1042/CS20090645.
10. Chim, S. S., Shing, T. K., Hung, E. C., Leung, T. Y., Lau, T. K., Chiu, R. W., et al. (2008). Detection and characterization of placental microRNAs in maternal plasma. Clin. Chem. 54, 482-490. doi: 10.1373/clinchem.2007.097972.
11. Collinson, P. O., Hadcocks, L., Foo, Y., Rosalki, S. B., Stubbs, P. J., Morgan, S. H., et al. (1998). Cardiac troponins in patients with renal dysfunction. Ann. Clin. Biochem. 35(Pt 3), 380-386.
12. Corsten, M. F., Dennert, R., Jochems, S., Kuznetsova, T., Devaux, Y., Hofstra, L., et al. (2010). Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ. Cardiovasc. Genet. 3, 499-506. doi: 10.1161/CIRCGENETICS.110.957415.
13. Da Costa Martins, P. A., and De Windt, L. J. (2012). MicroRNAs in control of cardiac hypertrophy. Cardiovasc. Res. 93, 563-572. doi: 10.1093/cvr/cvs013.
14. Dickinson, B. A., Semus, H. M., Montgomery, R. L., Stack, C., Latimer, P. A., Lewton, S. M., et al. (2013). Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure. Eur. J. Heart Fail. 15, 650-659. doi: 10.1093/eurjhf/hft018.
15. Eitel, I., Adams, V., Dieterich, P., Fuernau, G., De Waha, S., Desch, S., et al. (2012). Relation of circulating MicroRNA-133a concentrations with myocardial damage and clinical prognosis in ST-elevation myocardial infarction. Am. Heart J. 164, 706-714. doi: 10.1016/j.ahj.2012.08.004.
16. Eurlings, L. W., Sanders-Van Wijk, S., Van Kimmenade, R., Osinski, A., Van Helmond, L., Vallinga, M., et al. (2012). Multimarker strategy for short-term risk assessment in patients with dyspnea in the emergency department: the MARKED (Multi mARKer Emergency Dyspnea)-risk score. J. Am. Coll. Cardiol. 60, 1668-1677. doi: 10.1016/j.jacc.2012.06.040.
17. Fan, K. L., Zhang, H. F., Shen, J., Zhang, Q., and Li, X. L. (2013). Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy. Indian Heart J. 65, 12-16. doi: 10.1016/j.ihj.2012.12.022.
18. Fichtlscherer, S., De Rosa, S., Fox, H., Schwietz, T., Fischer, A., Liebetrau, C., et al. (2010). Circulating microRNAs in patients with coronary artery disease. Circ. Res. 107, 677-684. doi: 10.1161/CIRCRESAHA.109.215566.
19. Fukushima, Y., Nakanishi, M., Nonogi, H., Goto, Y., and Iwai, N. (2011). Assessment of plasma miRNAs in congestive heart failure. Circ. J. 75, 336-340. doi: 10.1253/circj.CJ-10-0457.
20. Gallo, A., Tandon, M., Alevizos, I., and Illei, G. G. (2012). The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS ONE 7:e30679. doi: 10.1371/journal.pone.0030679.
21. Gladka, M. M., Da Costa Martins, P. A., and De Windt, L. J. (2012). Small changes can make a big difference-microRNA regulation of cardiac hypertrophy. J. Mol. Cell Cardiol. 52, 74-82. doi: 10.1016/j.yjmcc.2011.09.015.
22. Goren, Y., Kushnir, M., Zafrir, B., Tabak, S., Lewis, B. S., and Amir, O. (2012). Serum levels of microRNAs in patients with heart failure. Eur. J. Heart Fail. 14, 147-154. doi: 10.1093/eurjhf/hfr155.
23. Gyorgy, B., Szabo, T. G., Pasztoi, M., Pal, Z., Misjak, P., Aradi, B., et al. (2011). Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell. Mol. Life Sci. 68, 2667-2688. doi: 10.1007/s00018-011-0689-3.
24. Halkein, J., Tabruyn, S. P., Ricke-Hoch, M., Haghikia, A., Nguyen, N. Q., Scherr, M., et al. (2013). MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J. Clin. Invest. 123, 2143-2154. doi: 10.1172/JCI64365.
25. Heijnen, H. F., Schiel, A. E., Fijnheer, R., Geuze, H. J., and Sixma, J. J. (1999). Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94, 3791-3799.
26. Hergenreider, E., Heydt, S., Treguer, K., Boettger, T., Horrevoets, A. J., Zeiher, A. M., et al. (2012). Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat. Cell Biol. 14, 249-256. doi: 10.1038/ncb2441.
27. Hoekstra, M., Van Der Lans, C. A., Halvorsen, B., Gullestad, L., Kuiper, J., Aukrust, P., et al. (2010). The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem. Biophys. Res. Commun. 394, 792-797. doi: 10.1016/j.bbrc.2010.03.075.
28. Hunter, M. P., Ismail, N., Zhang, X., Aguda, B. D., Lee, E. J., Yu, L., et al. (2008). Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 3:e3694. doi: 10.1371/journal.pone.0003694.
29. Jaffe, A. S., Ravkilde, J., Roberts, R., Naslund, U., Apple, F. S., Galvani, M., et al. (2000). It's time for a change to a troponin standard. Circulation 102, 1216-1220. doi: 10.1161/01.CIR.102.11.1216.
30. Januzzi, J. L., Van Kimmenade, R., Lainchbury, J., Bayes-Genis, A., Ordonez-Llanos, J., Santalo-Bel, M., et al. (2006). NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur. Heart J. 27, 330-337. doi: 10.1093/eurheartj/ehi631.
31. Kamm, R. C., and Smith, A. G. (1972). Ribonuclease activity in human plasma. Clin. Biochem. 5, 198-200. doi: 10.1016/S0009-9120(72)80033-X.
32. Kampoli, A. M., Tousoulis, D., Antoniades, C., Siasos, G., and Stefanadis, C. (2009). Biomarkers of premature atherosclerosis. Trends Mol. Med. 15, 323-332. doi: 10.1016/j.molmed.2009.06.001.
33. Kosaka, N., Iguchi, H., and Ochiya, T. (2010). Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 101, 2087-2092. doi: 10.1111/j.1349-7006.2010.01650.x.
34. Kroh, E. M., Parkin, R. K., Mitchell, P. S., and Tewari, M. (2010). Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50, 298-301. doi: 10.1016/j.ymeth.2010.01.032.
35. Laulagnier, K., Motta, C., Hamdi, S., Roy, S., Fauvelle, F., Pageaux, J. F., et al. (2004). Mast cell-and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. Biochem. J. 380, 161-171. doi: 10.1042/BJ20031594.
36. Lawless, N., Foroushani, A. B., McCabe, M. S., O'Farrelly, C., and Lynn, D. J. (2013). Next generation sequencing reveals the expression of a unique miRNA profile in response to a Gram-positive bacterial infection. PLoS ONE 8:e57543. doi: 10.1371/journal.pone.0057543.
37. Lawrie, C. H., Gal, S., Dunlop, H. M., Pushkaran, B., Liggins, A. P., Pulford, K., et al. (2008). Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 141, 672-675. doi: 10.1111/j.1365-2141.2008.07077.x.
38. Lee, L. W., Zhang, S., Etheridge, A., Ma, L., Martin, D., Galas, D., et al. (2010). Complexity of the microRNA repertoire revealed by next-generation sequencing. RNA 16, 2170-2180. doi: 10.1261/rna.2225110.
39. Libby, P., Ridker, P. M., and Hansson, G. K. (2011). Progress and challenges in translating the biology of atherosclerosis. Nature 473, 317-325. doi: 10.1038/nature10146.
40. Long, G., Wang, F., Duan, Q., Yang, S., Chen, F., Gong, W., et al. (2012). Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction. PLoS ONE 7:e50926. doi: 10.1371/journal.pone.0050926.
41. Mathivanan, S., Ji, H., and Simpson, R. J. (2010). Exosomes: extracellular organelles important in intercellular communication. J. Proteomics 73, 1907-1920. doi: 10.1016/j.jprot.2010.06.006.
42. Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., et al. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U.S.A. 105, 10513-10518. doi: 10.1073/pnas.0804549105.
43. Mittelbrunn, M., Gutierrez-Vazquez, C., Villarroya-Beltri, C., Gonzalez, S., Sanchez-Cabo, F., Gonzalez, M. A., et al. (2011). Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun. 2, 282. doi:10.1038/ncomms1285.
44. Norata, G. D., Sala, F., Catapano, A. L., and Fernandez-Hernando, C. (2013). MicroRNAs and lipoproteins: a connection beyond atherosclerosis? Atherosclerosis 227, 209-215. doi: 10.1016/j.atherosclerosis.2012.11.019.
45. Pant, S., Hilton, H., and Burczynski, M. E. (2012). The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem. Pharmacol. 83, 1484-1494. doi: 10.1016/j.bcp.2011.12.037.
46. Pigati, L., Yaddanapudi, S. C., Iyengar, R., Kim, D. J., Hearn, S. A., Danforth, D., et al. (2010). Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS ONE 5:e13515. doi: 10.1371/journal.pone.0013515.
47. Qi, R., Weiland, M., Gao, X. H., Zhou, L., and Mi, Q. S. (2012). Identification of endogenous normalizers for serum microRNAs by microarray profiling: U6 small nuclear RNA is not a reliable normalizer. Hepatology 55, 1640-1642; author reply 1642-1643. doi: 10.1002/hep.25558.
48. Salic, K., and De Windt, L. J. (2012). MicroRNAs as biomarkers for myocardial infarction. Curr. Atheroscler. Rep. 14, 193-200. doi: 10.1007/s11883-012-0238-z.
49. Small, E. M., and Olson, E. N. (2011). Pervasive roles of microRNAs in cardiovascular biology. Nature 469, 336-342. doi: 10.1038/nature09783.
50. Thery, C., Amigorena, S., Raposo, G., and Clayton, A. (2006). Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. Chapter 3, Unit 3 22. doi: 10.1002/0471143030.cb0322s30.
51. Tijsen, A. J., Creemers, E. E., Moerland, P. D., De Windt, L. J., Van Der Wal, A. C., Kok, W. E., et al. (2010). MiR423-5p as a circulating biomarker for heart failure. Circ. Res. 106, 1035-1039. doi: 10.1161/CIRCRESAHA.110.218297.
52. Trams, E. G., Lauter, C. J., Salem, N. Jr., and Heine, U. (1981). Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim. Biophys. Acta 645, 63-70. doi: 10.1016/0005-2736(81)90512-5.
53. Turchinovich, A., Weiz, L., and Burwinkel, B. (2012). Extracellular miRNAs: the mystery of their origin and function. Trends Biochem. Sci. 37, 460-465. doi: 10.1016/j.tibs.2012.08.003.
54. Turchinovich, A., Weiz, L., Langheinz, A., and Burwinkel, B. (2011). Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39, 7223-7233. doi: 10.1093/nar/gkr254.
55. Tutarel, O., Dangwal S., Bretthauer, J., Westhoff-Bleck, M., Roentgen, P., Anker, S. D., et al. (2011). Circulating miR-423_5p fails as a biomarker for systemic ventricular function in adults after atrial repair for transposition of the great arteries. Int. J. Cardiol. 167, 63-66. doi: 10.1016/j.ijcard.2011.11.082.
56. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J. J., and Lotvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659. doi: 10.1038/ncb1596.
57. van Empel, V. P., De Windt, L. J., and Da Costa Martins, P. A. (2012). Circulating miRNAs: reflecting or affecting cardiovascular disease? Curr. Hypertens. Rep. 14, 498-509. doi: 10.1007/s11906-012-0310-7.
58. Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D., and Remaley, A. T. (2011). MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13, 423-433. doi: 10.1038/ncb2210.
59. Vrijsen, K. R., Sluijter, J. P., Schuchardt, M. W., Van Balkom, B. W., Noort, W. A., Chamuleau, S. A., et al. (2010). Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells. J. Cell. Mol. Med. 14, 1064-1070. doi: 10.1111/j.1582-4934.2010.01081.x. .
60. Wang, G. K., Zhu, J. Q., Zhang, J. T., Li, Q., Li, Y., He, J., et al. (2010a). Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur. Heart J. 31, 659-666. doi: 10.1093/eurheartj/ehq013.
61. Wang, K., Zhang, S., Weber, J., Baxter, D., and Galas, D. J. (2010b). Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 38, 7248-7259. doi: 10.1093/nar/gkq601.
62. Weber, J. A., Baxter, D. H., Zhang, S., Huang, D. Y., Huang, K. H., Lee, M. J., et al. (2010). The microRNA spectrum in 12 body fluids. Clin. Chem. 56, 1733-1741. doi: 10.1373/clinchem.2010.147405.
63. World Health Organization, (2013). Cardiovascular Diseases. Available at: http://www.who.int/cardiovascular_diseases/en/ [accessed March 27, 2013].
64. Yang, M., Chen, J., Su, F., Yu, B., Lin, L., Liu, Y., et al. (2011). Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol. Cancer 10, 117. doi: 10.1186/1476-4598-10-117.
65. Zampetaki, A., Willeit, P., Tilling, L., Drozdov, I., Prokopi, M., Renard, J. M., et al. (2012). Prospective study on circulating MicroRNAs and risk of myocardial infarction. J. Am. Coll. Cardiol. 60, 290-299. doi: 10.1016/j.jacc.2012.03.056.
66. Zernecke, A., Bidzhekov, K., Noels, H., Shagdarsuren, E., Gan, L., Denecke, B., et al. (2009). Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal. 2, ra81. doi: 10.1126/scisignal.2000610.
67. Zhang, Y., Liu, D., Chen, X., Li, J., Li, L., Bian, Z., et al. (2010). Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell. 39, 133-144. doi: 10.1016/j.molcel.2010.06.010.
68. Zhou, R., O'Hara, S. P., and Chen, X. M. (2011). MicroRNA regulation of innate immune responses in epithelial cells. Cell. Mol. Immunol. 8, 371-379. doi: 10.1038/cmi.2011.19.